乙型肝炎的治疗：何人、何时以及如何治疗？ - Suppr

Treatment of hepatitis B: who, when, and how?

作者信息

Wong Stephen N, Lok Anna S F

出版信息

Arch Intern Med. 2006 Jan 9;166(1):9-12. doi: 10.1001/archinte.166.1.9.

DOI:10.1001/archinte.166.1.9

PMID:16401805

Abstract

摘要

相似文献

Treatment of hepatitis B: who, when, and how?

Arch Intern Med. 2006 Jan 9;166(1):9-12. doi: 10.1001/archinte.166.1.9.

A double-blind placebo-controlled study of emtricitabine in chronic hepatitis B.

Arch Intern Med. 2006 Jan 9;166(1):49-56. doi: 10.1001/archinte.166.1.49.

Changing landscape of antiviral resistance management in chronic hepatitis B.

J Gastroenterol Hepatol. 2008 Sep;23(9):1314-7. doi: 10.1111/j.1440-1746.2008.05551.x.

Antiviral therapy of chronic hepatitis B.

Antiviral Res. 2006 Sep;71(2-3):206-15. doi: 10.1016/j.antiviral.2006.04.003. Epub 2006 Apr 25.

[Modern strategy in the treatment of chronic hepatitis B: progress and prospects].

Eksp Klin Gastroenterol. 2007(2):107-12.

[Managing resistance to analogue antiviral drugs in a chronic compensated hepatitis B patient].

Gastroenterol Clin Biol. 2006 Oct;30(10 Pt 2):3S17-9.

HBV Chronic hepatitis during chemotherapy - an immune controlled disease.

J Gastrointestin Liver Dis. 2008 Dec;17(4):445-9.

Chronic hepatitis B: back to the future with HBsAg.

Expert Rev Anti Infect Ther. 2009 Aug;7(6):633-6. doi: 10.1586/eri.09.57.

Treatment of children persistently infected with hepatitis B virus: seroconversion or suppression.

J Antimicrob Chemother. 2007 Dec;60(6):1189-92. doi: 10.1093/jac/dkm362. Epub 2007 Oct 3.

Can serum HBV-DNA be used as a primary end point to assess efficacy of new treatments for chronic hepatitis B?

Hepatology. 2003 Jul;38(1):18-20. doi: 10.1053/jhep.2003.50280.

引用本文的文献

A deep learning model with data integration of ultrasound contrast-enhanced micro-flow cines, B-mode images, and clinical parameters for diagnosing significant liver fibrosis in patients with chronic hepatitis B.

Eur Radiol. 2023 Aug;33(8):5871-5881. doi: 10.1007/s00330-023-09436-z. Epub 2023 Feb 3.

Serum GP73 - An Additional Biochemical Marker for Liver Inflammation in Chronic HBV Infected Patients with Normal or Slightly Raised ALT.

Sci Rep. 2019 Feb 4;9(1):1170. doi: 10.1038/s41598-018-36480-3.

Serum Golgi protein 73 (GP73) is a diagnostic and prognostic marker of chronic HBV liver disease.

Medicine (Baltimore). 2015 Mar;94(12):e659. doi: 10.1097/MD.0000000000000659.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Treatment of hepatitis B: who, when, and how?

作者信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

Treatment of hepatitis B: who, when, and how?

作者信息

出版信息

相似文献

引用本文的文献